Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
CrossRef A Clinical-Imaging Nomogram for Predicting Early Recurrence in Patients with Solitary Hepatocellular Carcinoma After Postoperative Adjuvant TACE Jiachen Liu, Xiurong Ding, Yanyan Zhang, Hongjun Li Journal of Hepatocellular Carcinoma .2025
This heavy reliance on GLP-1-related products is a double-edged sword fantastic when those products are growing, but a vulnerability if growth stalls
In August 2018, the FDA issued a drug safety communication about the risk of Fourniers gangrene from Farxiga, Invokana, and similar diabetes drugs
A 2025 cohort study by Wang and colleagues found that patients on GLP-1s had a 20% to 50% lower risk of developing or relapsing into alcohol use disorder
Good for 28-30 days once reconstituted
US$ 21.34
US$ 26.83
US$ 20.74
